Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™
K. Murphy (Boys Town, NE, United States of America), R. Zeiger (San Diego and Pasadena, CA, United States of America), D. Beuther (Denver, CO, United States of America), J. Reibman (New York, NY, United States of America), R. Wise (Baltimore, MD, United States of America), W. Mccann (Asheville, NC, United States of America), I. Gilbert (Wilmington, DE, United States of America), J. Eudicone (Wilmington, DE, United States of America), H. Gandhi (Wilmington, DE, United States of America), K. Coyne (Bethesda, MD, United States of America), M. Ross (Bethesda, MD, United States of America), M. George (New York, NY, United States of America), B. Chipps (Sacramento, CA, United States of America)
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Session: Clinical and functional evaluation of asthmatics
Session type: E-poster session
Number: 2646
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Murphy (Boys Town, NE, United States of America), R. Zeiger (San Diego and Pasadena, CA, United States of America), D. Beuther (Denver, CO, United States of America), J. Reibman (New York, NY, United States of America), R. Wise (Baltimore, MD, United States of America), W. Mccann (Asheville, NC, United States of America), I. Gilbert (Wilmington, DE, United States of America), J. Eudicone (Wilmington, DE, United States of America), H. Gandhi (Wilmington, DE, United States of America), K. Coyne (Bethesda, MD, United States of America), M. Ross (Bethesda, MD, United States of America), M. George (New York, NY, United States of America), B. Chipps (Sacramento, CA, United States of America). Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™. 2646
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: